XML 49 R29.htm IDEA: XBRL DOCUMENT v3.25.0.1
Organization, Basis of Presentation and Liquidity (Tables)
12 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Lineage's Ownership of Outstanding Shares of its Subsidiaries

Subsidiary

 

Field of Business

 

Lineage
Ownership

 

Country

Cell Cure Neurosciences Ltd.

 

Manufacturing of Lineage’s product candidates

 

94%(1)

 

Israel

ES Cell International Pte. Ltd.

 

Research and clinical grade cell lines

 

100%

 

Singapore

 

(1)
Includes shares owned by Lineage and ES Cell International Pte. Ltd. (“ESI”).